Terms of Reference
Clinical trials and disclosure of data
Oral evidence
22 April 2013
Dr Catherine Elliott, Director of Clinical Research Interests, Medical Research Council, Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities, Professor Peter Johnson, Chief Clinician, Cancer Research UK, and Nicola Perrin, Head of Policy, Wellcome Trust; Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry, Dr James Shannon, Chief Medical Officer, GlaxoSmithKline, William M Burns, Member of the Board of Directors, Roche, and Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, London School of Hygiene and Tropical Medicine
13 March 2013
Professor Sir Michael Rawlins, Chair of the Academy of Medical Sciences Regulation and Governance Review, Dr Keith Bragman, President, Faculty of Pharmaceutical Medicine, and Dr Fiona Godlee, Editor in Chief, British Medical Journal
Written evidence
Clinical trials